Eli Lilly from September 5 will split its business unit Lilly Bio-Medicines into two: Lilly Neuroscience and Lilly Immunology. The first one will be headed by the president of Lilly Oncology Ann White. And Lilly Immunology will be headed by Lilly vice president in the U.S. Patrik Jonsson.